Ceftriaxone induced pancreatitis: A case report with review of literature
Although rare, clinicians should consider ceftriaxone as a potential cause of acute pancreatitis, especially when no other causes are evident. Prompt discontinuation of the drug typically results in rapid clinical and biochemical improvement.
Authors
- Sami Hammami (ORCID: https://orcid.org/0009-0006-7833-1602)
- Chakib Marrakchi (ORCID: https://orcid.org/0000-0003-1592-1868)
- K. Mnif (ORCID: https://orcid.org/0000-0001-7199-7168)
- R. Sahnoun
- Khaled Zghal
- B. Hammami
- Makram Koubâa (ORCID: https://orcid.org/0000-0002-6531-1083)
- S. Ben Hmida (ORCID: https://orcid.org/0000-0002-6057-0297)
- Tarak Ben Jemaa
- I. Boughariou
- Mounir Ben Jemâa (ORCID: https://orcid.org/0000-0002-3532-7623)
- Inès Bartégi (ORCID: https://orcid.org/0000-0001-9471-4909)
Institutions
- University of Sfax (TN)
- Hopital Universitaire Hedi Chaker (TN)
Publication Details
- Journal
- IDCases
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.idcr.2025.e02273
- Citations
- 1
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01